A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia
NOT ENROLLING
Trial ID:
NCT04086264 Protocol # :
19-606
Phase
I/II
Disease Sites
Myeloid and Monocytic Leukemia
Principal Investigator
DeAngelo, Daniel, J
Site Investigator
McMasters, Malgorzata
Mendez, Lourdes
Site Research Nurses
Tichon, Jennifer
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #19-606
19-606